McKesson slips as Q2 outlook underwhelms Source: Seekingalpha
Browsing: Healthcare
Perspective gets FDA fast track status for radiopharmaceutical VMT01 Source: Seekingalpha
Cigna to offer biosimilar to J&J’s arthritis drug Stelara at $0 out-of-pocket Source: Seekingalpha
Eli Lilly bets $409M for AI-focused drug discovery Source: Seekingalpha
Lisata jumps on FDA orphan drug status for liver cancer drug Source: Seekingalpha
Ascendis raised to outperform by Oppenheimer ahead of drug launch Source: Seekingalpha
Vor Bio stock rallies post-market on trem-cel study data Source: Seekingalpha
aTyr started at buy by Jefferies, citing efzofitimod potential Source: Seekingalpha
Kits Eyecare announces $10.15M secondary offering Source: Seekingalpha
Fanhua and Shanghai Biotecan Pharmaceuticals enters into cooperation agreement Source: Seekingalpha
